Carlo M. Castellani
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 126 publications
Vanzacaftor-Tezacaftor as an alternative therapeutic resource for the ETI-Resistant L467F-F508del Allele: Ex vivo prediction and exploratory clinical assessment.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: February 05, 2026
Timing and rate of reimbursement for cystic fibrosis modulator therapies in EU countries.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: January 27, 2026
The role of sweat chloride in determining CFTR protein restoration in people with cystic fibrosis.
Journal: The Lancet. Respiratory medicine
Published: August 29, 2025
Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR.
Journal: Frontiers in pharmacology
Published: July 07, 2025
Elexacaftor/tezacaftor/ivacaftor for cystic fibrosis and rare CFTR variants: in vitro translation to a phase 3, double-blind, randomized, placebo-controlled trial, and real-world study.
Journal: American journal of respiratory and critical care medicine
Published: June 13, 2025
In silico, in vitro and ex vivo characterization of cystic fibrosis transmembrane conductance regulator pathogenic variants localized in the fourth intracellular loop and their rescue by modulators.
Journal: British journal of pharmacology
Published: March 14, 2025
Therapeutic Drug Monitoring of Elexacaftor, Tezacaftor, and Ivacaftor: An Overview of Bioanalytical Methods.
Journal: Therapeutic drug monitoring
Published: March 08, 2025
Primary Lung Tumors in Children: Insights from a Single-Center Case Series.
Journal: Journal of clinical medicine
Published: January 28, 2025
A Novel LC-MS/MS Method for the Measurement of Elexacaftor, Tezacaftor and Ivacaftor in Plasma, Dried Plasma Spot (DPS) and Whole Blood in Volumetric Absorptive Microsampling (VAMS) Devices.
Journal: Pharmaceutics
Published: December 23, 2024
Critical Issues in the Management of CRMS/CFSPID Children: A National Real-World Survey.
Journal: Pediatric pulmonology
Published: September 12, 2024
Pharmacological rescue of the G85E CFTR variant by preclinical and approved modulators.
Journal: Frontiers in pharmacology
Published: September 10, 2024
Last Updated: 09/26/2026